AgomAb Therapeutics NV Stock Price, News & Analysis
Company Description
AgomAb Therapeutics NV (NASDAQ: AGMB) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $527.6M, ranking #3,417 among all listed U.S. companies by market cap.
AGMB stock has declined 26.8% over the past year. Shares last traded at $10.72.
This page provides a comprehensive overview of AGMB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AgomAb Therapeutics NV (AGMB) stock last traded at $10.72, down 2.24% from the previous close. Over the past 12 months, the stock has lost 26.8%. At a market capitalization of $527.6M, AGMB is classified as a small-cap stock with approximately 48.7M shares outstanding.
Latest News
AgomAb Therapeutics NV has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include IPO, offering. View all AGMB news →
SEC Filings
AgomAb Therapeutics NV has filed 5 recent SEC filings, including 5 Form 3. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AGMB SEC filings →
Financial Highlights
Upcoming Events
Phase 1b patient results
AgomAb Therapeutics NV has 1 upcoming scheduled event. The next event, "Phase 1b patient results", is scheduled for September 1, 2026 (in 148 days). Investors can track these dates to stay informed about potential catalysts that may affect the AGMB stock price.
Short Interest History
Short interest in AgomAb Therapeutics NV (AGMB) currently stands at 166.6 thousand shares, down 15.8% from the previous reporting period, representing 1.3% of the float. Over the past 12 months, short interest has increased by 41.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for AgomAb Therapeutics NV (AGMB) currently stands at 2.0 days, up 99% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 99% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.0 days.
AGMB Company Profile & Sector Positioning
AgomAb Therapeutics NV (AGMB) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.